-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Moderna, Raises Price Target to $67

Benzinga·07/21/2026 12:41:20
Listen to the news
Goldman Sachs analyst Salveen Richter maintains Moderna (NASDAQ:MRNA) with a Neutral and raises the price target from $49 to $67.